Hurts is clinically stable and has no significant functional limitations, the statement said. He is taking anticoagulants, commonly called blood thinners, and will not play football while on the medication. The statement said his prognosis is very good and he is expected to make a full recovery, with a return to contact football possible once he is off the medication.

The Eagles placed Hurts on injured reserve before Sunday’s game against the Carolina Panthers. His calf issue first surfaced Oct. 8, after he reported being cleated during a game against the Los Angeles Rams four days earlier. An ultrasound after the team traveled to London for its Week 5 matchup initially showed a superficial clot. Hurts played against the Jacksonville Jaguars in London, a game the Eagles lost on a last-second field goal.

The later diagnosis was deep vein thrombosis and bilateral pulmonary emboli, meaning clots in both lungs. Dr. Parth Rali, a Temple Health specialist who directs its pulmonary embolism response team, said blood thinners are standard treatment and that patients generally cannot play contact sports while taking them because of bleeding risks. Rali said treatment typically lasts at least three months.

Eagles coach Nick Sirianni declined to discuss the medical decision-making around Hurts’ appearance in London, saying the team relies on its medical staff. “The health of our players is always at the forefront of our mind,” Sirianni said Monday. “We leave that up to the medical experts.”

The team and Lynn said Hurts will remain involved with the Eagles and keep in shape during his recovery. They expect him to have no long-term effects.